Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Pulse Biosciences, Inc. | Director | Stock Option (right to buy) | 11.6K | Jun 6, 2024 | Direct | ||
PhaseBio Pharmaceuticals Inc | Director | Common Stock | 0 | May 19, 2023 | Direct | ||
PhaseBio Pharmaceuticals Inc | Director | Restricted Stock Units | 0 | May 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PLSE | Pulse Biosciences, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 24, 2024 | Director |
PLSE | Pulse Biosciences, Inc. | May 25, 2023 | 2 | $0 | 4 | Jun 6, 2023 | Director |
PHASQ | PhaseBio Pharmaceuticals Inc | May 19, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
PLSE | Pulse Biosciences, Inc. | May 19, 2022 | 2 | $0 | 4 | May 23, 2022 | Director |
PHASQ | PhaseBio Pharmaceuticals Inc | May 19, 2022 | 2 | $0 | 4 | May 20, 2022 | Director |
PHASQ | PhaseBio Pharmaceuticals Inc | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
PLSE | Pulse Biosciences, Inc. | May 20, 2021 | 2 | $0 | 4 | May 21, 2021 | Director |